What stage is age 45?
Menopause is a single day — the 12-month anniversary of your final menstrual period. The years leading up to it are called perimenopause, and the years after are post-menopause. Clinicians use the STRAW+10 staging system to map where a woman is in the transition based on cycle regularity, FSH levels, and symptoms.
At age 45, most women are in the late perimenopause / early-normal onset category. For a personalized STRAW+10-based estimate, use our free perimenopause stage estimator — it takes 2 minutes and is not a diagnosis.
Typical symptoms at age 45
Not everyone experiences all symptoms, and severity ranges from mild to debilitating. Below are the patterns most commonly reported at this age, based on SWAN (Study of Women's Health Across the Nation) longitudinal data and NAMS clinical summaries.
- Skipped periods and cycles ≥60 days apart
- Frequent hot flashes
- Night sweats
- Insomnia
- Joint pain
- Mood changes
- Vaginal dryness beginning
Is menopause at 45 considered early?
No. Menopause between 45 and 55 is considered the typical window, with the US median at 51. No hormone bloodwork is required for diagnosis in most cases — a clinical history of 12 consecutive months without a period is sufficient (NAMS 2022 position statement).
Treatment considerations at 45
Treatment is individualized. The main evidence-based options include:
- Menopausal hormone therapy (MHT/HRT) — systemic estrogen ± progestogen for vasomotor symptoms and bone protection. NAMS 2022: benefits generally outweigh risks when started before 60 or within 10 years of menopause.
- Vaginal estrogen — low-dose topical formulations for genitourinary symptoms; safe long-term for most patients.
- Non-hormonal medications — SSRIs/SNRIs (paroxetine, venlafaxine), gabapentin, oxybutynin, or fezolinetant (Veozah, FDA-approved 2023) for vasomotor symptoms.
- Lifestyle — resistance training for bone density, sleep hygiene, CBT for hot flashes, dietary adjustments.
Cost and telehealth options
Direct-to-consumer menopause telehealth in the US falls into three price bands:
- Bundled subscription — $49–$99/month: consultation + generic medication + follow-ups (e.g. Winona, Evernow, Alloy).
- Membership + pass-through pharmacy — $89–$150/month membership; medication billed separately at cost. Often accepts insurance (e.g. Midi Health).
- Concierge / clinical-first model — $199–$399 initial visit + follow-ups. Broader lab work, longer visits, in-network insurance more common.
Compare side-by-side on our brands directory, or narrow by insurance acceptance on /by-insurance.
Frequently asked questions
- Is menopause at 45 normal?
- Yes — the US median age of the final menstrual period is around 51, so 45 falls within the typical range. Some vasomotor and genitourinary symptoms are common; the World Health Organization notes the menopause transition can last 4–8 years.
- What are the earliest signs of menopause at 45?
- The most common early signs at 45 include skipped periods and cycles ≥60 days apart, frequent hot flashes, night sweats. According to the STRAW+10 staging system used clinically, cycle-length variability of ≥7 days is often the first objective marker of the menopause transition.
- How is menopause diagnosed at 45?
- After age 45, menopause is diagnosed clinically — 12 consecutive months without a period — without needing hormone bloodwork in most cases (NAMS 2022 position statement). FSH testing has limited value in this age group because levels fluctuate during perimenopause.
- Should I consider hormone therapy (HRT / MHT) at 45?
- NAMS 2022 position: for symptomatic women who initiate menopausal hormone therapy before age 60 or within 10 years of menopause, benefits generally outweigh risks. The decision is individualized based on symptom burden, personal and family history.
- How much does menopause telehealth cost at 45?
- Direct-to-consumer menopause telehealth in the US typically ranges $49–$150/month for consultation + medication (bundled), or $89–$399 for initial visit + pass-through pharmacy costs. Insurance coverage varies by state and plan. See our /brands directory for side-by-side pricing.
Sources
- PubMedHarlow SD et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab. 2012;97(4):1159-68.
- NAMSThe 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. 2022;29(7):767-794.
- ACOGACOG Committee Opinion No. 698: Hormone Therapy in Primary Ovarian Insufficiency. Obstet Gynecol. 2017;129(5):e134-e141.
- WHOWorld Health Organization. Menopause fact sheet (2024).
- NIHNIH Office of Research on Women's Health. Menopause and menopausal symptoms overview.